Development
Bruker Corporation
BRKR
$34.54
$2.186.74%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 19.82% | 16.26% | 15.89% | 14.99% | 3.04% |
| Total Other Revenue | 111.29% | -- | -- | 92.86% | 210.00% |
| Total Revenue | 20.62% | 16.26% | 15.89% | 15.18% | 3.64% |
| Cost of Revenue | 22.59% | 18.18% | 18.00% | 12.79% | 0.97% |
| Gross Profit | 18.79% | 14.53% | 13.86% | 17.42% | 6.28% |
| SG&A Expenses | 25.70% | 18.21% | 13.00% | 11.51% | 6.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 300.00% | 162.75% | 123.81% | 0.00% | -41.38% |
| Total Operating Expenses | 25.29% | 20.98% | 17.74% | 13.40% | 3.19% |
| Operating Income | 0.96% | -1.65% | 5.02% | 23.75% | 5.59% |
| Income Before Tax | 98.60% | -7.79% | 11.64% | 14.15% | 1.84% |
| Income Tax Expenses | 58.55% | -25.24% | 0.00% | -6.27% | -46.21% |
| Earnings from Continuing Operations | 108.14% | 0.34% | 16.30% | 24.64% | 29.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 200.00% | -100.00% | -250.00% | -80.00% | -200.00% |
| Net Income | 110.99% | 0.00% | 15.35% | 24.19% | 28.67% |
| EBIT | 0.96% | -1.65% | 5.02% | 23.75% | 5.59% |
| EBITDA | 8.79% | 2.21% | 8.02% | 22.33% | 5.74% |
| EPS Basic | 113.32% | 0.82% | 17.10% | 27.22% | 32.34% |
| Normalized Basic EPS | 20.30% | -4.00% | 14.32% | 20.44% | 4.78% |
| EPS Diluted | 112.72% | 1.69% | 17.88% | 26.95% | 35.01% |
| Normalized Diluted EPS | 20.52% | -3.95% | 14.26% | 20.57% | 5.06% |
| Average Basic Shares Outstanding | -1.09% | -0.81% | -1.48% | -2.39% | -2.78% |
| Average Diluted Shares Outstanding | -1.28% | -0.87% | -1.40% | -2.51% | -3.02% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 25.00% |
| Payout Ratio | -0.53% | 0.00% | -0.16% | -0.21% | -0.04% |